MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from maturities
of short-term...
$468,401K
Proceeds from long-term
debt, net of issuance...
$73,022K
Issuance of class a
ordinary shares, net of...
$72,395K
Proceeds from stock
options...
$480K
Proceeds from stock
options...
$100K
Net cash flow
provided by (used in)...
$202,992K
Net cash flow
provided by financing...
$145,997K
Effect of movements in
exchange rates on cash...
$1,109K
Canceled cashflow
$265,409K
Net change in cash
and cash...
$154,091K
Canceled cashflow
$196,007K
Purchase of short-term
marketable debt securities
$265,374K
Purchase of property and
equipment
$35K
Trade and other
payables
$20,560K
Share-based compensation
expense
$12,898K
Depreciation and
amortization
$2,616K
Accrued expenses and
other current...
$2,591K
Prepaid expenses
-$561K
Net cash flow used in
operating activities
-$196,007K
Canceled cashflow
$39,226K
Net loss
-$230,321K
Other receivables
$2,025K
Operating lease
liabilities
-$1,222K
Other non-cash items
$1,020K
Other non-current
assets
$587K
Net periodic
pension benefit (gain)...
-$58K
Back
Back
Cash Flow
source: myfinsight.com
MoonLake Immunotherapeutics (MLTX)
MoonLake Immunotherapeutics (MLTX)